Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Bonus plan approved
Inv. presentation
Acq. announced
Director departure
|
|
CUBIST PHARMACEUTICALS INC (CBST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/23/2015 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 02/17/2015 |
SC 13G
| ARISTEIA CAPITAL LLC reports a 5.8% stake in Cubist Pharmaceuticals Inc. |
| 02/13/2015 |
SC 13G/A
| FMR LLC reports a 10.7% stake in CUBIST PHARMACEUTICALS INC |
| 02/10/2015 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.2% stake in Cubist Pharmaceuticals Inc |
| 02/10/2015 |
SC 13G/A
| FMR LLC reports a 2.3% stake in CUBIST PHARMACEUTICALS INC |
| 01/27/2015 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 01/22/2015 |
SC TO-I
| Form SC TO-I - Tender offer statement by Issuer: |
| 01/22/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/21/2015 |
4
| MOULDER LEON O JR (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
| 01/21/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/21/2015 |
4
| MARTIN KENNETH J (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed/sold 14,686 options to buy
@ $64.341, valued at
$944.9k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
| 01/21/2015 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 4,717 shares
@ $102, valued at
$481.1k
Disposed/sold 10,842 options to buy
@ $40.59, valued at
$440.1k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
| 01/21/2015 |
4
| HENNEY JANE E MD (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 4,644 shares
@ $102, valued at
$473.7k
Disposed/sold 10,176 options to buy
@ $42.64, valued at
$433.9k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
| 01/21/2015 |
4
| Hutson Nancy J (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 5,951 shares
@ $102, valued at
$607k
Disposed/sold 16,519 options to buy
@ $21.01, valued at
$347.1k
Disposed/sold 9,472 options to buy
@ $38.06, valued at
$360.5k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
| 01/21/2015 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
| 01/21/2015 |
4
| BATE KENNETH (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
| 01/21/2015 |
4
| VINK PATRICK V.J.J. (EVP and COO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
| 01/21/2015 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 14,765 shares
@ $102, valued at
$1.5M
Disposed of 1,199 shares
@ $102, valued at
$122.3k
Disposed/sold 1,500 restricted stock units
@ $0
Disposed/sold 5,875 options to buy
@ $34.795, valued at
$204.4k
Disposed/sold 10,000 options to buy
@ $42.09, valued at
$420.9k
Disposed/sold 1,667 restricted stock units
@ $0
Disposed/sold 15,000 options to buy
@ $43.81, valued at
$657.2k
Disposed/sold 2,500 restricted stock units
@ $0
Disposed/sold 18,404 options to buy
@ $41.6, valued at
$765.6k
Disposed/sold 2,253 restricted stock units
@ $0
Disposed/sold 3,004 options to buy
@ $0 |
|
| 01/21/2015 |
4
| PEREZ ROBERT J (CEO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 47,325 shares
@ $102, valued at
$4.8M
Disposed of 5,012 shares
@ $102, valued at
$511.2k
Disposed/sold 25,000 options to buy
@ $23.12, valued at
$578k
Disposed/sold 50,000 options to buy
@ $21.91, valued at
$1.1M
Disposed/sold 40,000 options to buy
@ $18.1, valued at
$724k
Disposed/sold 62,500 options to buy
@ $16.76, valued at
$1M
Disposed/sold 75,000 options to buy
@ $21.56, valued at
$1.6M
Disposed/sold 5,000 restricted stock units
@ $0
Disposed/sold 100,000 options to buy
@ $34.795, valued at
$3.5M
Disposed/sold 100,000 options to buy
@ $42.09, valued at
$4.2M
Disposed/sold 10,000 restricted stock units
@ $0 |
|
| 01/21/2015 |
4
| GILMAN STEVEN C (EVP & Chief Scientific Officer) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 27,680 shares
@ $102, valued at
$2.8M
Disposed of 2,851 shares
@ $102, valued at
$290.8k
Disposed/sold 1,000 options to buy
@ $16.76, valued at
$16.8k
Disposed/sold 60,000 options to buy
@ $21.56, valued at
$1.3M
Disposed/sold 9,375 options to buy
@ $25.23, valued at
$236.5k
Disposed/sold 3,500 restricted stock units
@ $0
Disposed/sold 21,875 options to buy
@ $34.795, valued at
$761.1k
Disposed/sold 75,000 options to buy
@ $42.09, valued at
$3.2M
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 47,851 options to buy
@ $41.6, valued at
$2M
Disposed/sold 5,859 restricted stock units
@ $0 |
|
| 01/21/2015 |
4
| DesRosier Thomas (EVP, Chief Legal) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 7,967 shares
@ $102, valued at
$812.6k
Disposed of 479 shares
@ $102, valued at
$48.9k
Disposed/sold 52,232 options to buy
@ $45.9, valued at
$2.4M
Disposed/sold 7,132 restricted stock units
@ $0
Disposed/sold 33,433 options to buy
@ $73.55, valued at
$2.5M
Disposed/sold 4,900 restricted stock units
@ $0
Disposed/sold 4,356 options to buy
@ $0 |
|
| 01/21/2015 |
4
| BONNEY MICHAEL W (CEO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 176,226 shares
@ $102, valued at
$18M
Disposed of 6,816 shares
@ $102, valued at
$695.2k
Disposed of 600 shares
@ $102, valued at
$61.2k
Disposed/sold 100,000 options to buy
@ $10.87, valued at
$1.1M
Disposed/sold 80,000 options to buy
@ $21.61, valued at
$1.7M
Disposed/sold 125,000 options to buy
@ $19.51, valued at
$2.4M
Disposed/sold 150,000 options to buy
@ $18.1, valued at
$2.7M
Disposed/sold 150,000 options to buy
@ $16.76, valued at
$2.5M
Disposed/sold 135,000 options to buy
@ $21.56, valued at
$2.9M
Disposed/sold 8,000 restricted stock units
@ $0
Disposed/sold 175,000 options to buy
@ $34.795, valued at
$6.1M
|
|
| 01/21/2015 |
8-K
| Quarterly results |
| 01/21/2015 |
SC 13G/A
| BlackRock Inc. reports a 7.9% stake in CUBIST PHARMACEUTICALS INC |
| 01/21/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/15/2015 |
SC 13G/A
| BlackRock Inc. reports a 9.2% stake in CUBIST PHARMACEUTICALS INC |
| 01/15/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/14/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/13/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/13/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/12/2015 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 3% stake in Cubist Pharmaceuticals, Inc. |
| 01/12/2015 |
SC 13G/A
| PUTNAM INVESTMENTS LLC reports a 2.9% stake in CUBIST PHARMACEUTICALS INC |
| 01/07/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/05/2015 |
4
| VINK PATRICK V.J.J. (EVP and COO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
|
|
|